The role of stem cell transplantation in Waldenstrom's macroglobulinemia
- 1 June 2016
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Haematology
- Vol. 29 (2), 229-240
- https://doi.org/10.1016/j.beha.2016.08.018
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2015
- Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results databaseBritish Journal of Haematology, 2014
- Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results databaseBlood, 2014
- Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasmsBlood, 2013
- MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reactionBlood, 2013
- MYD88 L265P Somatic Mutation in Waldenström's MacroglobulinemiaThe New England Journal of Medicine, 2012
- Temporal and geographic variations of Waldenstrom macroglobulinemia incidenceCancer, 2011
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- The incidence and survival of Waldenström's Macroglobulinaemia in South East EnglandLeukemia Research, 2008
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003